Abramson Cancer Center Support Grant
艾布拉姆森癌症中心支持补助金
基本信息
- 批准号:10425591
- 负责人:
- 金额:$ 19.94万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2022-08-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAddressAdherenceAfrica South of the SaharaAfricanAftercareBotswanaCancer Center Support GrantCancer SurvivorCaringCessation of lifeCharacteristicsClinicClinicalConsolidated Framework for Implementation ResearchCountryDataDeveloping CountriesDiagnosisEarly DiagnosisEarly treatmentEnsureFutureGeographyGoalsGrantGynecologic OncologyHIVHIV InfectionsHospitalsIncidenceIncomeInterventionInterviewMalignant NeoplasmsMalignant neoplasm of cervix uteriMethodsMorbidity - disease rateOutcomePatient-Focused OutcomesPatientsPatternPersonsPrevalencePrivate HospitalsQuality of lifeRadiation therapyRecommendationResearchResourcesScientific Advances and AccomplishmentsShapesStructureSurveysTestingWomanWorkadvanced diseaseanticancer researchcare deliverycare outcomescohortcontextual factorscurative treatmentsdemographicsexperiencefallsimprovedinfection rateinterestlow and middle-income countriesmortalitymultidisciplinaryoutreach clinicspsychosocialresponsescreeningsurvivorshiptransportation accesstumoruptake
项目摘要
PROJECT SUMMARY
This application is being submitted in response to the Notice of Special Interest (NOSI) identified as NOT-CA-
21-058. The number of cancer survivors living in low- and middle-income countries (LMICs) is expected to grow
rapidly over the next decade driven in part by global advances in early detection and treatment, yet very little is
known about the long-term needs of cancer survivors or delivery of survivorship care in LMICs. This supplement
application will help to fill this critical research gap by quantitatively and qualitatively evaluating care outcomes
and contextual determinants of survivorship care among women diagnosed with cervical cancer in Botswana.
Cervical cancer is one of the leading cancers among women globally with 600,000 new cases and 340,000
deaths annually per 2020 estimates. Cervical cancer is an acquired immunodeficiency syndrome (AIDS)-defining
malignancy, and countries with high rates of human immunodeficiency virus (HIV) have higher incidence of
cervical cancer. Due to high HIV-infection rates and suboptimal screening uptake, most of the burden of cervical
cancer incidence, morbidity, and mortality falls on LMICs particularly in sub-Saharan Africa, with many women
presenting with advanced disease. Botswana, a sub-Saharan African country, has high rates of cervical cancer
(incidence rate of 34.4 per 100,000) and HIV (18.5% prevalence), and a high rate of mortality due to cervical
cancer (20.1 per 100,000) among women. To date, the majority of cancer research in Botswana and other LMICs
has focused on early detection or treatment, with limited research evaluating the long-term physical or
psychosocial outcomes in survivorship or how survivorship care may impact these outcomes. Furthermore, even
less is known regarding which approaches may be most impactful and sustainable to deliver survivorship care
in LMICs. As such, there is a critical need to understand the current state of survivorship in LMICs and to identify
effective strategies to ensure that all women receive optimal survivorship care. The objectives of this project are
to: 1) quantitatively describe a) patterns in post-treatment survivorship care and b) long-term physical and
psychosocial sequelae of cervical cancer using an existing cohort of patients at Princess Marina Hospital in
Gaborone, Botswana; and 2) qualitatively assess contextual determinants (e.g., quality of life, access to
resources, care delivery strategies) shaping patient experiences and adherence to survivorship care. In
combination, these data will be used to develop and/or adapt survivorship care interventions to target the specific
contextual determinants in Botswana and other LMICs. The results of this project will advance scientific
understanding of survivorship care and sequelae in LMICs and how these experiences may or may not differ
from the experiences and needs of cancer survivors in high-income countries. This project will also generate
fundamental evidence needed to improve survival and quality of life of cancer survivors globally. The long-term
goal of this project is to decrease cervical cancer mortality in Botswana and other LMICs by developing and
implementing survivorship care interventions that can be sustained in lower resource settings.
项目摘要
本申请是为了响应被标识为NOT-CA的特别利益通知(NOSI)而提交的-
21-058.生活在低收入和中等收入国家(LMIC)的癌症幸存者人数预计将增加
在未来十年中,部分由于全球在早期发现和治疗方面的进步,
了解癌症幸存者的长期需求或在中低收入国家提供生存护理。这种补充剂
应用程序将有助于通过定量和定性评估护理结果来填补这一关键的研究空白
博茨瓦纳被诊断为宫颈癌的妇女中生存护理的背景决定因素。
宫颈癌是全球女性中最主要的癌症之一,每年有60万新发病例,
2020年每年死亡人数估计数。宫颈癌是一种获得性免疫缺陷综合征(艾滋病)的定义
人类免疫缺陷病毒(HIV)感染率高的国家,
宫颈癌由于高艾滋病毒感染率和次优的筛查吸收,宫颈癌的大部分负担
低收入国家的癌症发病率、发病率和死亡率福尔斯下降,特别是在撒哈拉以南非洲,许多妇女
出现了晚期疾病博茨瓦纳是撒哈拉以南的非洲国家,宫颈癌发病率很高
(发病率为每100 000人34.4)和艾滋病毒(流行率为18.5%),宫颈癌死亡率很高,
妇女中的癌症(每100 000人中有20.1人)。迄今为止,博茨瓦纳和其他中低收入国家的大多数癌症研究
一直专注于早期发现或治疗,评估长期身体或
生存的心理社会结果或生存护理如何影响这些结果。而且就算
关于哪种方法可能最有效和可持续地提供生存护理,
在中低收入国家。因此,迫切需要了解中低收入国家的生存现状,
制定有效战略,确保所有妇女获得最佳生存护理。本项目的目标是
目的:1)定量描述a)治疗后生存护理模式和B)长期身体和
使用Princess Marina医院现有患者队列研究宫颈癌的心理社会后遗症
哈博罗内,博茨瓦纳;和2)定性评估上下文的决定因素(例如,生活质量,获得
资源,护理提供策略)塑造患者的经验和坚持生存护理。在
结合使用,这些数据将用于制定和/或调整生存护理干预措施,以针对特定的
博茨瓦纳和其他中低收入国家的背景决定因素。该项目的成果将推动科学
了解中低收入国家的生存护理和后遗症,以及这些经验可能会或可能不会有所不同
从高收入国家癌症幸存者的经历和需求中。该项目还将产生
改善全球癌症幸存者的生存和生活质量所需的基本证据。长期
该项目的目标是通过开发和实施一种新的治疗方法,
实施生存护理干预措施,在资源较低的情况下可以持续。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ROBERT H VONDERHEIDE其他文献
ROBERT H VONDERHEIDE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ROBERT H VONDERHEIDE', 18)}}的其他基金
Immunotherapy and Tumor Microenvironment in HIV/AIDS Cancer Patients
HIV/艾滋病癌症患者的免疫治疗和肿瘤微环境
- 批准号:
10249752 - 财政年份:2019
- 资助金额:
$ 19.94万 - 项目类别:
non-AIDS defining cancers (NADCs) among aging HIV+ individuals
老年艾滋病毒感染者中的非艾滋病定义癌症(NADC)
- 批准号:
10249743 - 财政年份:2019
- 资助金额:
$ 19.94万 - 项目类别:
Project 1: Clinical and immune impact of radiation and dual checkpoint blockade in patients
项目 1:辐射和双重检查点封锁对患者的临床和免疫影响
- 批准号:
10005190 - 财政年份:2017
- 资助金额:
$ 19.94万 - 项目类别:
相似海外基金
Pharmacy-led Transitions of Care Intervention to Address System-Level Barriers and Improve Medication Adherence in Socioeconomically Disadvantaged Populations
药房主导的护理干预转型,以解决系统层面的障碍并提高社会经济弱势群体的药物依从性
- 批准号:
10594350 - 财政年份:2023
- 资助金额:
$ 19.94万 - 项目类别:
Evaluating Centralizing Interventions to Address Low Adherence to Lung Cancer Screening Follow-up in Decentralized Settings
评估集中干预措施,以解决分散环境中肺癌筛查随访依从性低的问题
- 批准号:
10738120 - 财政年份:2023
- 资助金额:
$ 19.94万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10526768 - 财政年份:2022
- 资助金额:
$ 19.94万 - 项目类别:
Suubi-Mhealth: A mobile health intervention to address depression and improve ART adherence among Youth living with HIV (YLHIV) in Uganda
Suubi-Mhealth:一种移动健康干预措施,旨在解决乌干达艾滋病毒感染者 (YLHIV) 青少年的抑郁症问题并提高抗逆转录病毒疗法的依从性
- 批准号:
10701072 - 财政年份:2022
- 资助金额:
$ 19.94万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10679092 - 财政年份:2021
- 资助金额:
$ 19.94万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10432133 - 财政年份:2021
- 资助金额:
$ 19.94万 - 项目类别:
A behavioral intervention for Black men who have sex with men and live with HIV to address intersectional stigma and improve antiretroviral therapy adherence
针对男男性行为且感染艾滋病毒的黑人男性进行行为干预,以解决交叉耻辱并提高抗逆转录病毒治疗的依从性
- 批准号:
10327065 - 财政年份:2021
- 资助金额:
$ 19.94万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10377366 - 财政年份:2019
- 资助金额:
$ 19.94万 - 项目类别:
Leveraging Technology to Address Access and Adherence to Conventional Hospital-Based Pulmonary Rehabilitation in Veterans with COPD
利用技术解决慢性阻塞性肺病退伍军人接受和坚持传统医院肺康复的问题
- 批准号:
10574496 - 财政年份:2019
- 资助金额:
$ 19.94万 - 项目类别:
Targeted interventions to address the multi-level effects of gender-based violence on PrEP uptake and adherence among adolescent girls and young women in Kenya
有针对性的干预措施,以解决性别暴力对肯尼亚少女和年轻妇女接受和坚持 PrEP 的多层面影响
- 批准号:
9403567 - 财政年份:2017
- 资助金额:
$ 19.94万 - 项目类别:














{{item.name}}会员




